Connect
MJA
MJA

Safety of hormone replacement therapy after mastectomy

Christopher B Del Mar, Paul P Glasziou, Anneliese B Spinks, Sharon L Sanders and Deborah J Hilton
Med J Aust 2002; 176 (6): 285.
Published online: 18 March 2002

After mastectomy, chemotherapy and radiotherapy for high-grade ductal carcinoma with nodal involvement and lymphatic infiltration, a 48-year-old woman had premature menopause, with symptoms of loss of libido. Her general practitioner wanted to know how safe and effective hormone replacement therapy (HRT) would be for this patient.

  • Christopher B Del Mar1
  • Paul P Glasziou2
  • Anneliese B Spinks3
  • Sharon L Sanders4
  • Deborah J Hilton5

  • Centre for General Practice, Medical School, University of Queensland, Herston, QLD.

Correspondence: c.delmar@cgp.uq.edu.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.